Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease

Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease

Background Current studies suggest mitochondrial dysfunction is a major contributor to impaired physical performance and exercise intolerance in chronic kidney disease (CKD). We conducted a clinical trial of coenzyme Q10 (CoQ10) and nicotinamide riboside (NR) to determine their impact on exercise to...

Full description

Bibliographic Details
Main Authors: Armin Ahmadi, Gwenaelle Begue, Ana P. Valencia, Jennifer E. Norman, Benjamin Lidgard, Brian J. Bennett, Matthew P. Van Doren, David J. Marcinek, Sili Fan, David K. Prince, Jorge Gamboa, Jonathan Himmelfarb, Ian H. de Boer, Bryan R. Kestenbaum, Baback Roshanravan
Format: Article
Language:English
Published: American Society for Clinical investigation 2023-06-01
Series:JCI Insight
Subjects:
Clinical trials
Nephrology
Online Access:https://doi.org/10.1172/jci.insight.167274

Internet

https://doi.org/10.1172/jci.insight.167274

Similar Items